The Drug Supply Chain Security Act (DSCSA) compliance deadlines are fast approaching, and despite recent political shifts, these deadlines remain firmly in place. The Trump administration’s regulatory freeze, introduced in
TrackTraceRX, a leading provider of innovative track-and-trace solutions, specializing in end-to-end visibility for the pharmaceutical supply chain, and Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming the pharmacy care delivery
The Drug Supply Chain Security Act (DSCSA) is a critical regulation aimed at ensuring that drug products are tracked and traced electronically across the supply chain. On October 9, 2024, the
The recent announcement from the FDA has sent waves through the pharmaceutical industry, reinforcing the urgency of the Drug Supply Chain Security Act (DSCSA) compliance. Patrizia Cavazzoni, Director of the
This smart management solution is already the number one choice for more than 7 million users. Discover its features and exclusive modules now!
TrackTraceRX has joined the OCI. Access our content to learn more about the OCI and how it helps pharmaceutical companies meet the DSCSA ATP requirement.
The recovery of the global economy and projected investments in new technologies have accelerated TrackTraceRX’s internationalization.
TrackTraceRX is opening its first unit outside the United States. Specialized in the development of technologies for traceability and serialization.
The TRXADE Marketplace is one of the most trusted marketplace for pharmacies and wholesalers with over 6000 members.
Shaping the future of traceability and serialization since 2007
